Search research articles
Contact Us
Filters
Showing results (71-80 of 79) with videos related to
Page
of 8
Sort By:
You have reached the last page of results.
This site can display upto 79 results.
Leukemia
|
August 1, 1992
Phase II study of mitoxantrone and 5-azacytidine for accelerated and blast crisis of chronic myelogenous leukemia: a study of the Eastern Cooperative Oncology Group
J P Dutcher, L Eudey, P H Wiernik, et al.
The American Journal of Medicine
|
February 1, 1984
Treatment of advanced Hodgkin's disease with chemotherapy and irradiation. Controlled trial of two versus three alternating, potentially non-cross-resistant drug combinations
D J Straus, J Myers, B J Lee, et al.
Blood
|
April 1, 1981
The significance of splenomegaly in 101 adults with acute lymphoblastic leukemia (ALL) at presentation and during remission
A Friedman, P Schauer, R Mertelsmann, et al.
Cancer Treatment Reports
|
April 1, 1982
Multidisciplinary treatment of advanced Hodgkin's disease by an alternating chemotherapeutic regimen of MOPP/ABDV and low-dose radiation therapy restricted to originally bulky disease
C W Young, D J Straus, J Myers, et al.
Biomedicine / [Publiee Pour L'A.A.I.C.I.G.]
|
December 1, 1979
Macrophage-like cell transformation and CFU(c) fluctuations in normal and leukemic human marrow cultures treated by phorbol diester
I A Svet-Moldavskaya, S N Zinzar, G J Svet-Moldavsky, et al.
Cancer Genetics and Cytogenetics
|
October 15, 1988
The karyotype of Philadelphia chromosome-negative, bcr rearrangement-positive chronic myeloid leukemia
M E Weinstein, A Grossman, M A Perle, et al.
Cancer
|
July 15, 1980
The eight-drug/radiation therapy program (MOPP/ABDV/RT) for advanced Hodgkin's disease: a follow-up report
D J Straus, J Myers, S Passe, et al.
Blood
|
November 1, 1982
Combination chemotherapy of advanced chronic lymphocytic leukemia: the M-2 protocol (vincristine, BCNU, cyclophosphamide, melphalan, and prednisone)
S Kempin, B J Lee, H T Thaler, et al.
Cancer
|
November 15, 1981
Treatment of acute nonlymphocytic leukemia in adults: response to 2,2-anhydro-1-B-D-arabinofuranosyl-5-fluorocytosine and thioguanine on the L-12 protocol
R Mertelsmann, R L Drapkin, T S Gee, et al.
Page
of 8
Search research articles
Search
Showing results (71-80 of 79) with videos related to
Sort By:
Page
of 8
You have reached the last page of results.
This site can display upto 79 results.
Leukemia
|
August 1, 1992
Phase II study of mitoxantrone and 5-azacytidine for accelerated and blast crisis of chronic myelogenous leukemia: a study of the Eastern Cooperative Oncology Group
J P Dutcher, L Eudey, P H Wiernik, et al.
The American Journal of Medicine
|
February 1, 1984
Treatment of advanced Hodgkin's disease with chemotherapy and irradiation. Controlled trial of two versus three alternating, potentially non-cross-resistant drug combinations
D J Straus, J Myers, B J Lee, et al.
Blood
|
April 1, 1981
The significance of splenomegaly in 101 adults with acute lymphoblastic leukemia (ALL) at presentation and during remission
A Friedman, P Schauer, R Mertelsmann, et al.
Cancer Treatment Reports
|
April 1, 1982
Multidisciplinary treatment of advanced Hodgkin's disease by an alternating chemotherapeutic regimen of MOPP/ABDV and low-dose radiation therapy restricted to originally bulky disease
C W Young, D J Straus, J Myers, et al.
Biomedicine / [Publiee Pour L'A.A.I.C.I.G.]
|
December 1, 1979
Macrophage-like cell transformation and CFU(c) fluctuations in normal and leukemic human marrow cultures treated by phorbol diester
I A Svet-Moldavskaya, S N Zinzar, G J Svet-Moldavsky, et al.
Cancer Genetics and Cytogenetics
|
October 15, 1988
The karyotype of Philadelphia chromosome-negative, bcr rearrangement-positive chronic myeloid leukemia
M E Weinstein, A Grossman, M A Perle, et al.
Cancer
|
July 15, 1980
The eight-drug/radiation therapy program (MOPP/ABDV/RT) for advanced Hodgkin's disease: a follow-up report
D J Straus, J Myers, S Passe, et al.
Blood
|
November 1, 1982
Combination chemotherapy of advanced chronic lymphocytic leukemia: the M-2 protocol (vincristine, BCNU, cyclophosphamide, melphalan, and prednisone)
S Kempin, B J Lee, H T Thaler, et al.
Cancer
|
November 15, 1981
Treatment of acute nonlymphocytic leukemia in adults: response to 2,2-anhydro-1-B-D-arabinofuranosyl-5-fluorocytosine and thioguanine on the L-12 protocol
R Mertelsmann, R L Drapkin, T S Gee, et al.
Page
of 8